Warrington, United Kingdom

Kenneth D Burrows

This inventor holds 1 USPTO granted patent. Top assignee: Imperial Chemical Industries Limited. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth D Burrows. Retrieved from https://idiyas.com/inventor/kenneth-d-burrows

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 88(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenneth D Burrows: Innovator in Anti-Tumor Compounds

Introduction

Kenneth D Burrows is a notable inventor based in Warrington, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with anti-tumor activity. His work has the potential to impact cancer treatment and improve patient outcomes.

Latest Patents

Kenneth D Burrows holds a patent for quinoline derivatives that exhibit anti-tumor properties. The patent describes a quinoline compound characterized by specific substituents, which include various functional groups that enhance its therapeutic efficacy. The compounds are designed to possess anti-tumor activity, making them valuable in the fight against cancer.

Career Highlights

Burrows is associated with Imperial Chemical Industries Limited, where he has been involved in innovative research and development. His work has led to advancements in the understanding and application of quinoline derivatives in medicinal chemistry.

Collaborations

Throughout his career, Kenneth has collaborated with esteemed colleagues such as Peter Warner and Leslie R Hughes. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field.

Conclusion

Kenneth D Burrows is a distinguished inventor whose work on quinoline derivatives has the potential to contribute significantly to cancer treatment. His innovative approach and collaborations highlight the importance of teamwork in advancing scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…